A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating bacterium responsible for severe infections such as necrotizing fasciitis. The research highlights how disrupting bacterial metabolism can help the body better tolerate infection and heal more effectively.
Inhibitor blocks flesh-eating bacteria’s metabolism, reducing tissue damage in infections
